Cargando…
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies
Autores principales: | Crombie, Jennifer L., Sherman, Amy C., Cheng, Chi-An, Ryan, Christine E., Zon, Rebecca, Desjardins, Michaël, Baker, Peter, McDonough, Mikaela, Izaguirre, Natalie, Bausk, Bruce, Krauss, Jonathan, Gilboa, Tal, Senussi, Yasmeen, Walt, David R., Davids, Matthew S., Brown, Jennifer R., Armand, Philippe, Baden, Lindsey R., Issa, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362656/ https://www.ncbi.nlm.nih.gov/pubmed/34387646 http://dx.doi.org/10.1182/bloodadvances.2021005328 |
Ejemplares similares
-
586. Immunogenicity of COVID-19 mRNA Vaccines in Patients with Lymphoid Malignancies
por: Izaguirre, Natalie E, et al.
Publicado: (2021) -
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies
por: Sherman, Amy C, et al.
Publicado: (2022) -
25. Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients
por: Bausk, Bruce P, et al.
Publicado: (2021) -
36. Safety and Reactogenicity of the Adjuvanted Recombinant Zoster Vaccine after Allogeneic Hematopoietic Stem Cell Transplantation
por: Baumrin, Emily, et al.
Publicado: (2020) -
Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series
por: Yonker, Lael M., et al.
Publicado: (2022)